News Digest / Income Statements / Burlington posts strong sales and margin recovery but capex and buybacks strain cash

Burlington posts strong sales and margin recovery but capex and buybacks strain cash

StockInvest.us
05:08pm, Thursday, Aug 28, 2025
Illustration by StockInvest.us

Burlington Stores, Inc. (NYSE: BURL) - quick internal read

What's happening inside: management is executing growth (store rollouts and supply‑chain buildout), driving higher sales and margin recovery, while funding heavy capital spending and refinancing debt. Results show clear top‑line momentum and margin improvement but pressure on cash flow and higher leverage from term‑loan activity and buybacks.

Key points and statistics (facts shown as reported)
* Net sales - Three months ended Aug 2, 2025: $2,701,026 (in thousands); six months: $5,201,101 (in thousands).
* Revenue growth - Q2 net sales up $239.8 million, or 9.7% vs prior year; six months up $382.6 million, or 7.9%.
* Comparable store sales - Q2: +5%; six months: +2% (company definition).
* Gross margin - Q2: 43.7% of net sales; six months: 43.8% (improved vs prior year).
* Net income - Q2: $94,185 (in thousands); six months: $195,018 (in thousands).
* EPS - Basic Q2: $1.49; Diluted Q2: $1.47. Six months basic: $3.09; diluted: $3.05.
* Adjusted results - Adjusted Net Income Q2: $101,757; six months: $204,339. Adjusted EBITDA Q2: $245,699; six months: $483,802 (in thousands).
* Costs and margins - Cost of sales Q2: $1,519,629; cost of sales rate improved to 56.3% of net sales (Q2). SG&A Q2: $949,931 (35.2% of net sales).
* Interest/Tax - Interest expense Q2: $17,427; six months: $33,237. Effective tax rate Q2: 26.0%; six months: ~25.0%.
* Impairments & other - Impairment charges Q2: $1,580; six months: $2,095. Other comprehensive loss (derivatives) Q2: $(10,165) net of tax.
* Inventory - Merchandise inventories at Aug 2, 2025: $1,414,814; comparable store inventories down 8% YoY; reserve inventory ~50% of total vs 41% prior year.
* Stores & ops - Opened 44 new stores (incl. 8 relocations) and closed 6 in the six‑month period; total stores: 1,138 as of Aug 2, 2025.
* Cash & liquidity - Cash and cash equivalents: $747,619. Working capital: $480.3 million. Available under ABL Line: $945.7 million.
* Debt & leases - Total debt (principal) reported: $2,039,305; long‑term debt, net of current maturities: $2,019,409. Term Loan balance (reported): $1,727,148. Operating lease assets/liabilities remain large (ROU assets: $3,542,956).
* Cash flow & capex - Net cash provided by operating activities (six months): $150,532 vs $209,806 prior year. Net cash used in investing activities (six months): $(581,414) driven by property & equipment purchases of $589,241. Capital expenditures (net of landlord allowances) for six months: $639.9 million; company expects ~ $950 million capex for fiscal 2025 (net of ~$55 million allowances).
* Share repurchases - Repurchased 547,759 shares for $131.1 million in the six months; $632.1 million remaining authorization as of Aug 2, 2025.
* Balance sheet snapshot - Total assets: $9,309,263; Total stockholders' equity: $1,446,817 (in thousands).

Positive aspects of the income statement
* Top‑line momentum: double‑digit Q2 sales lift (+9.7%/$239.8M) and positive comps (+5% Q2).
* Margin recovery: gross margin expanded to ~43.7-43.8%, driven by lower markdowns and decreased freight.
* Profitability gains: net income and adjusted metrics increased meaningfully year‑over‑year (Adjusted EBITDA and Adjusted EBIT show solid operating leverage).
* Disciplined inventory strategy: lower comparable store inventory (‑8%) and strategic reserve inventory to chase trends.

Negative aspects / risks reflected in the income statement and notes
* Cash generation weakness: operating cash flow declined materially vs prior year (six months: $150.5M vs $209.8M) while capex surged - capex is starving free cash flow in the near term.
* Heavy investment cadence and working capital build: large spending on supply chain and ~81 net new stores since last year increased inventory and CAPEX needs.
* Leverage: long‑term debt rose (Term Loan up materially after amendments and incremental loans) - interest expense is meaningful (~$17.4M Q2) despite swaps; fair‑value and original‑issue discounts complicate effective rates.
* Hedging losses hit OCI: substantial unrealized losses on interest‑rate swaps reduced accumulated other comprehensive income and will reclassify to interest expense (~$11.5M estimated next 12 months).
* Share repurchases while investing: management continues buybacks (repurchases and treasury stock), which consumes cash during a heavy capex phase.
* Non‑recurring charges: impairment and pre‑opening costs from bankruptcy‑acquired leases, plus litigation charges, add volatility.

Bottom line - where the company stands:
Burlington is growing stores and sales while regaining margin - the core retail operating story is positive. However, aggressive capex (supply‑chain and store growth), active buybacks and incremental term‑loan funding increase near‑term cash strain and leverage. Liquidity is supported by a sizable undrawn ABL and a management view that available cash plus ABL will cover needs, but investors should watch operating cash conversion, capex progress, and the path for leverage reduction as new stores and distribution investments mature.

Watch next
* Quarterly operating cash conversion and free‑cash‑flow vs guidance on $950M FY capex.
* Comparable store sales sustainment beyond promotional windows and the effectiveness of the "chase the sales trend" inventory approach.
* Interest expense trends as swaps roll and the company reclassifies OCI to earnings.
* Progress on new distribution centers (capitalization and subsequent operating efficiencies) and whether these investments drive the promised cost savings.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.